Cancel

Occurrence and Implications of Chemotherapy-Induced Nausea and Vomiting (CINV)

Oncology nursing professionals play a key role in the care of patients receiving chemotherapy. However, to do so, they require access to the most recent clinical information and guidance, the latest developments in CINV therapy, and expanded knowledge of CINV pathophysiology. In addition, oncology nursing professionals need continuing education focused on appropriate screening in order to better identify patients at risk of CINV before chemotherapy begins, and developing the skills to undertak...
American Academy of CME

Immunotherapy: Harnessing the Immune System to Treat Cancer

This educational activity is directed toward oncology nurses and nurse practitioners caring for patients receiving cancer immunotherapy. Learning Objectives Upon completion of this activity, the participant will be able to: 1. List the various types of immunotherapy currently used in the management of malignancies 2. Summarize the various mechanisms of action for the different immunotherapy agents 3. Describe various toxicities for specific types of immunotherapy 4. Explain specific...
Medical Learning Institute

Optimizing Nursing Management of Hepatic Veno-Occlusive Disease

STATEMENT OF NEED Veno-occlusive disease (VOD), also known as sinusoidal obstruction syndrome, is a potentially life-threatening complication of hematopoietic stem cell transplant (HSCT), characterized by weight gain, fluid retention with ascites, tender hepatomegaly, and jaundice. The toxicity is believed to result from damage to hepatic sinusoidal endothelial cells, which causes obstructed sinusoidal flow that leads to liver dysfunction, multiorgan failure, and death. The incidence of VOD...
i3 Health

Patient-Centered Care of Metastatic Colon and Rectal Cancer

This educational activity is directed toward oncology nurses and nurse practitioners who have expressed a need for educational programming on the coordination of care, management of adverse events, counseling and education, and patient follow-up in metastatic colon and rectal cancer (mCRC). Such education would allow these healthcare professionals to take on leadership roles in the multi-disciplinary care of mCRC, leading to improved patient outcomes. Learning Objectives At the conclusion...
Medical Learning Institute

Selecting Optimal Antiangiogenic Strategies for Patients With Hepatocellular Carcinoma

STATEMENT OF NEED Hepatocellular carcinoma is the sixth most common tumor globally, with an increasing incidence in the United States and Europe. The malignancy is the third leading cause of cancer-related death worldwide and the leading cause of death in patients with cirrhosis. Approximately 40,710 new cases are diagnosed in the United States annually and 28,920 people die of the disease. Patients with HCC continue to have a dismal prognosis, with a 5-year survival rate of 18%. This is du...
Postgraduate Institute for Medicine and i3 Health

Hematology/Oncology PICU Issues: Case Studies

Learning Objectives: Review the importance of hemoglobin, coagulation, bone marrow, fibrinolytic and transfusion issues with the critically ill child. Describe the diagnostic laboratory data necessary to care for the child with anemia, platelet disorders, and oncologic emergencies. Prioritize the care for the child with an oncologic emergency.
Contemporary Forums

Defining Personalized Care Plans in Metastatic Castration-Resistant Prostate Cancer

STATEMENT OF NEED Prostate cancer is the most common tumor type among men in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Metastatic CRPC is the primary cause of prost...
Postgraduate Institute for Medicine and i3 Health

Selecting Optimal Therapeutic Strategies for Patients With Differentiated and Medullary Thyroid Cancer

STATEMENT OF NEED Thyroid cancer is one of the most prevalent cancers in the United States. An estimated 56,870 new cases are diagnosed annually, and 2,010 people die of the disease (ACS, 2017). Thyroid cancer is typically more aggressive in men than women and becomes increasingly lethal in those older than age 40 (NCCN, 2016). There are three primary subtypes: differentiated (including papillary, follicular, and Hürthle), medullary, and anaplastic. The differentiated subtype is the most c...
Penn State College of Medicine and i3 Health

Appraisal of Recent Progress in Metastatic Castration-Resistant Prostate Cancer: Current Trends and Future Directions

STATEMENT OF NEED Prostate cancer is the most common tumor type in the United States. Typically, androgen deprivation therapy is administered for progressive disease. However, castration resistance or unresponsiveness to androgen deprivation therapy or to antiandrogens frequently develops over time. The transition from castration-sensitive to castration-resistant disease has yet to be understood and represents a significant unmet need. Metastatic castration-resistant prostate cancer is the ...
University of Cincinnati and i3 Health

Melanoma: Updates from Brisbane, Australia The latest data in melanoma reported at the joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma

Roxana S. Dronca, MD, and Lisa A. Kottschade, APRN, MSN, CNP, offer their expert insights into recent data on advanced melanoma presented at a joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research. Listen to what these experts have to say about combination therapy in the adjuvant setting for metastatic melanoma, real-world utilization of checkpoint inhibitor therapy, sequencing options for BRAF +/- MEK Inhibition following immu...
Annenberg Center for Health Sciences at Eisenhower

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

STATEMENT OF NEED Carcinoid syndrome refers to a constellation of symptoms caused by the systemic release of humoral factors such as polypeptides, biogenic amines, and prostaglandins, mostly from well-differentiated neuroendocrine tumors. Patients frequently experience flushing, abdominal cramps, bronchospasms, hypotension, and diarrhea, which lead to impaired quality of life and daily functioning. In addition, complications such as carcinoid heart disease and mesenteric and/or retroperiton...
Postgraduate Institute for Medicine and i3 Health

Critical Care of Patients With Cancer

After reading the article “Critical Care of Patients with Cancer,” the learner should be able to: 1. Describe the evolution of critical care for cancer patients. 2. Relate key principles of intensive care for critically ill cancer patients. 3. Discuss the referral and management of critically ill cancer patients in the ICU. 4. Define the long term impact of intensive care treatment on cancer patients, their relatives and caregivers.
American Cancer Society

The Next Evolution in Cancer Therapy: 2016

As the number of cancer therapies grow at unprecedented rates, it is hard for the general pharmacist to keep up to date. Many of these drugs are oral and, while the pharmacist may not directly work with these agents, they need to be aware of their toxicities as well as interactions with other drugs. This presentation will give a general overview of the newly approved drugs within the last year, where they fall within the armamentarium of cancer-fighting agents and important information that th...
MCPHS University

Live CE/CME Conference aboard Alaska Cruise

Day 1: Pharmacogenomics : Guided therapy in Psychiatry, Cardiology and Oncology (5 hrs) Day 2: Transcranial Magnetic Stimulation-A novel FDA approved non invasive and non pharmacological treatment for Major Depressive Disorder (2.5 hrs) Day 3: Designer Drugs and Opioids: Identification of Patients who present with manifestation, screening tools, and management. (2.5 hrs) Day 4:Pediatric Autism Spectrum: An Overview (2 hrs) Drug Shortages and its Impact on Patient Safety and Medica...
University Learning Systems

OCN® Exam Review - Mission Hills

This program is designed for oncology nurses seeking a general oncology review in preparation for the ONCC® OCN Exam. We will focus on the following categories from the 2016 OCN blueprint: cancer epidemiology, health promotion and cancer screening, scientific basis for practice, treatment modalities, symptom management, psychosocial care, oncologic emergencies, palliative/end-of-life care and survivorship. This is not meant to be an introductory course, but rather a comprehensive review of ba...
MED-ED

The Oncologist: Cancer Incidence in First and Second Degree Relatives of BRCA1 and BRCA2 Mutation Carriers

Learning Objectives: 1. Discuss known risks of cancers in BRCA1 and BRCA2 mutation carriers. 2. Cite data from a single institution regarding other cancers described in families of known BRCA mutation carriers. Background. Mutations in the BRCA1 and BRCA2 genes are associated with increased risk of breast, ovarian, and several other cancers. The purpose of the present study was to evaluate the incidence of cancer in first- and second-degree relatives of BRCA mutation carriers compared wi...
Society For Translational Oncology

The Oncologist: Efficacy and Safety of Everolimus in Extrapancreatic Neuroendocrine Tumor: A Comprehensive Review of Literature

Learning Objectives: 1. Describe the use of everolimus in clinical practice. 2. Discuss the possibility of using everolimus in neuroendocrine tumors other than pancreatic. 3. Recount the safety profile of everolimus. Background. Everolimus, an oral mTOR (mammalian target of rapamycin) inhibitor, is currently approved for the treatment of progressive pancreatic neuroendocrine tumors (NETs). Although promising, only scattered data, often from nondedicated studies, are available for extrap...
Society For Translational Oncology

But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents

The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT...
freeCE.com

Contemporary Management of von Willebrand Disease in Women: Identifying Bleeding Disorders and Preventing Hemorrhage

According to the National Hemophilia Foundation, underdiagnosis of bleeding disorders in women is a significant problem. Menorrhagia associated with bleeding disorders such as von Willebrand disease (VWD) is an overlooked, undertreated, and potentially serious condition that often has a profound impact on the affected individual’s quality of life. For women with VWD, menorrhagia is almost inevitable, with prevalence ranging from 32% to as high as 100%. Lack of awareness of the high prevalenc...
CMEology

28th Annual Mayo Clinic Hematology/Oncology Reviews 2018

This course is a comprehensive review of hematology/oncology that focuses on the application of new clinical and research advancements and developments over the preceding year. The most important clinical management questions in hematology/oncology will be addressed in highly interactive sessions. Attendees will leave with up-to-date, practical information which will have immediate clinical application. Attendees are encouraged to bring portable computer devices to view the syllabus on the co...
Mayo Clinic

But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents

The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT...
freeCE.com

Expert Update: What's New in Essential Thrombocythemia

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms (MPNs) to enhance clinical outcomes and patient quality of life. Recent revisions in the classification of myeloid neoplasms and acute leukemia by the World Health Organization have further defined criteria for the differential diagnosis of MPNs, including criteria for the discernment of essential thrombocythemia (ET) and prefibrotic/early primary myelofibrosis. However, many ch...
Slack Inc.

The Oncologist: Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

Learning Objectives: 1. Explain the differences between right- and left-sided colorectal cancer in terms of clinical and molecular characteristics. 2. Describe the response of RAS and BRAF wild-type right-sided colorectal cancer to anti-EGFRs. Introduction. Right- and left-sided colorectal cancers (CRCs) differ in clinical and molecular characteristics. Some retrospective analyses suggested that patients with right-sided tumors derive less benefit from anti-epidermal growth factor recept...
Society For Translational Oncology

The Oncologist: Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers

Learning Objectives: 1. Discuss the bleomycin-induced pulmonary (BIP) changes that occur on restaging CT scans after treatment with bleomycin-containing chemotherapy in testicular cancer patients. 2. Discuss the use of an upfront or early biomarker to identify patients likely to develop BIP. Background. In metastatic testicular cancer patients treated with bleomycin, etoposide, and cisplatin (BEP) chemotherapy, bleomycin-induced pneumonitis is a well-known and potentially fatal side effe...
Society For Translational Oncology

The Oncologist: A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer

Learning Objectives: 1. Discuss the range of issues that survivors of colorectal cancer may experience. 2. Critically review interventions and models of care that aim to better meet the needs of survivors. 3. Critically review endpoints for studies that aim to improve the wellbeing of survivors and recognize challenges with study endpoints. Introduction. Colorectal cancer (CRC) and its treatments can cause distressing sequelae. We conducted a multicenter randomized controlled trial aimi...
Society For Translational Oncology

The Oncologist: Sarcomas Associated With Genetic Cancer Predisposition Syndromes: A Review

Learning Objectives: 1. Discuss the heritable cancer predisposition syndromes associated with specific sarcomas. 2. Explain the broad therapeutic principles of major sarcomas. 3. Describe the influence of genetic cancer predisposition on treatment of sarcoma and broader clinical management of the patient. Sarcomas are rare mesenchymal malignancies that demonstrate great clinical and biological heterogeneity. A variety of sarcomas develop in the context of well-defined heritable cancer pr...
Society For Translational Oncology

An Overview of Biosimilars: Potential Implications for Pharmacists

This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). Most CSPE activities include the pathophysiology and clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice. Learning Objectives The target audience for this a...
ProCE

Communication for Healthcare Providers and Oncology Care Coninuum for PCP's Western Caribbean Cruise

The purpose is to provide an update on the oncology care continuum and new strategies for communication, teamwork and work-life balance for practitioners. Caring for the Caregiver- Work-life Balance ◦Using a self-awareness worksheet- including professional goals, values and priorities- identify concerns and steps to strengthen and sustain worklife balance. Decisions ◦Select appropriate directive, consultative, democratic and consensus approaches to decisions in order to achieve desir...
Continuing Education, Inc

Scale, Bail, or Fail – The CDK4/6 Inhibition Edition

Preclinical and clinical findings suggest that CDK4/6 inhibition may confer therapeutic benefits in numerous tumor types and improve outcomes in patients with mantle cell lymphoma, liposarcoma, melanoma, and non–small cell lung cancer. Additionally, studies of CDK4/6 inhibition of cancers of the prostate, lung, skin, and central nervous system are currently under way. In the format of an entertaining (but challenging!) interactive game, this edition of Scale, Bail or Fail presents and dis...
University of Cincinnati and RedMedEd

But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents

The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT...
freeCE.com

Lung Cancer Screening

LEARNING OBJECTIVES Upon completion of the activity, participants should be able to: •Review historical RCTs of lung cancer screening •Explore the purpose and utility of the ACR Lung-RADS™ •Identify individuals who may benefit from lung cancer screening
The France Foundation

Staging and Diagnosis of Lung Cancer

Upon completion of the activity, participants should be able to: •Discuss the role of imaging in lung cancer diagnosis and staging •Review descriptors identified in the 8th Edition of TNM Staging for Lung Cancer •Review methods for tissue acquisition for lung cancer diagnosis and mediastinal staging
The France Foundation

Image-Guided Thermal Ablation of Lung Cancer

Upon completion of the activity, participants should be able to: •Explore recognized standards of care for thermal ablation of NSCLC as reflected in relevant treatment guidance, with special attention to imaging-related concerns and combination of IO and conventional treatment •Review clinical trial data describing efficacy and safety of ablative therapies
The France Foundation

Lung Cancer Pathology: From Atypical Adenomatous Hyperplasia to Adenocarcinoma

Upon completion of the activity, participants should be able to: •Explore lung adenocarcinoma classification, with a focus on the transition from pre-invasive to invasive adenocarcinoma •Examine how imaging and molecular testing inform histologic findings in lung adenocarcinoma classification and comprehension of the transition from pre-invasive to invasive disease •Describe data supporting this carcinoma progression paradigm
The France Foundation

Lung Cancer: Standard of Care Treatment Algorithms (Chemotherapy/Immunotherapy)

Upon completion of the activity, participants should be able to: •Review the current treatment algorithms for lung cancer •Identify appropriate roles for systemic therapy in various stages of lung cancer •Explain tumor-specific factors that influence selection of systemic treatment modalities
The France Foundation

The Role of Surgery for Non-Small Cell Lung Cancer

Upon completion of the activity, participants should be able to: •Explore different surgical approaches to NSCLC •Determine the extent of resection required based on the patient’s surgical risk and tumor factors •Review data from clinical trials examining the role of different surgical strategies of patients with NSCLC
The France Foundation

Lung Cancer

Activity Description This is a featured CE activity on the Center for Specialty Pharmacy Education (CSPE) website. CSPE is the educational hub of the National Association of Specialty Pharmacy (NASP). Most CSPE activities include the pathophysiology and clinical therapeutics of various disease states in which specialty pharmacy products and services are provided. CSPE also covers legal, regulatory and operational topics relevant to specialty pharmacy practice. Learning Objectives The targ...
ProCE

The Oncologist: Impact of Oncologists’ Attitudes toward End-of-Life Care on Patient’s Access to Palliative Care

Learning Objectives: 1. Discuss the association between oncologists’ EOL care attitudes and timely specialist palliative care referral. 2. Discuss the association between oncologists’ EOL care attitudes and provision of supportive care. 3. Discuss the association between oncologists’ EOL care attitudes and EOL cancer treatment decisions. Background. It is unclear how oncologists’ attitudes toward end-of-life (EOL) care affect the delivery of care. The present study examined the...
Society For Translational Oncology

The Oncologist: Breast Camps for Awareness and Early Diagnosis of Breast Cancer in Countries with Limited Resources: A Multidisciplinary Model from Kenya

Learning Objectives: 1. Describe the components of the breast camp demonstration program and the differences in design and outcomes at the three clinical sites. 2. Describe the results of the breast camps and what they suggest for future guidelines for screening, early detection and treatment of breast cancer in Kenya. 3. Identify potential barriers that need to be overcome in order to set up an early diagnosis and treatment program in Kenya. Background. Breast cancer is the most common...
Society For Translational Oncology

A Comprehensive Board Review in Hematology and Medical Oncology

www.mdanderson.org/conferences
MD Anderson

Conventional and Stereotactic Radiotherapy for Lung Cancer

Upon completion of the activity, participants should be able to: •Distinguish the main types of radiation therapy (conventional and stereotactic) used for lung cancer •Discuss outcomes for Stage III lung cancer with various conventional treatment approaches •Explain recent experience with stereotactic ablative radiotherapy (SAbR), especially for treatment of patients with Stage I tumors •Describe ongoing clinical trials examining the use of local therapy (eg, SAbR) in patients wi...
The France Foundation

12th Northeast Regional Hematology Oncology Pharmacists Symposium

Two day conference for pharmacists and nursing specializing in hematology/oncology. • 13 contact hours offered-2 law • Network with industry professionals • Enjoy breakfast, lunch, dinner & cocktail reception • Low fee to attend- including meals: Both days: Member-$140, Non members-$160 One day: Member-$110, Non member-$125
American Health Resources, LLC

But I Don't Dispense Those! A Community Pharmacist's Guide to Immuno-Oncology Agents

The promise of the immune system in helping to treat cancer has finally become a reality in the past few years. The immune system is designed to differentiate between normal cells foreign cells. To do this, it uses “checkpoints” – molecules on certain immune cells that need to be activated (or inactivated) to start an immune response. Cancer cells often may look like normal cells and may evade the immune system recognition. An important molecule in this process is CTLA4 and thus a CT...
freeCE.com

ADME, PK/TK, and Drug Metabolism in Drug Discovery and Development

The content of this overview course will assist pharmaceutical, biotechnology, and CRO researchers and managers in understanding the requirements for a well-designed and successful ADME, PK/TK, and DM program conducted within a drug development logic plan and in compliance with ICH guidelines. The various types of ADME, PK/TK, and DM studies, which include in vitro metabolism and delivery, animal and human pharmacokinetics, protein binding, mass balance, tissue distribution, metabolite isolati...
The Center for Professional Innovation and Education

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

This “Ace the Case” study will utilize a case study to discuss the treatment of 48-year-old female who was diagnosed with polycythemia vera (PV) 7 years ago. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
Slack Inc.

11th International Congress on Myeloproliferative Neoplasms

Since its inception 17 years ago, the International Congress on Myeloproliferative Neoplasms has provided a forum for the interaction of practicing hematologists, oncologists, translational scientists, and other healthcare professionals with experts from both the US and Europe in the myeloproliferative neoplasms, including chronic myeloid leukemia, the hyper-eosinophilic syndromes and mastocytosis. This year’s program will feature the latest information on the pathophysiology and management ...
Melton Medical Education, LLC

Mayo Clinic Pancreatic and Hepato-Biliary Cancer Symposium 2018

Nationally and internationally renowned faculty bring you a state-of-the-art update on the latest multi-disciplinary care for patients with hepato-biliary and pancreatic cancers. There will also be a focus on emerging immuno-oncology and molecular profiling options.
Mayo Clinic

3rd Annual Cutaneous Oncology Symposium 2018

This two-day course focuses on ten controversial topics in cutaneous oncology covering the fields of dermatology, surgical oncology, radiation oncology and medical oncology. The goal is to discuss the available evidence of these topics to assist in making the most informed decisions.
Mayo Clinic

The Oncologist: Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges

Learning Objectives: 1. Discuss the relevance of immunogenicity in oncology. 2. Cite the effects of anti-drug antibodies on pharmacokinetics, efficacy, and toxicity. 3. Describe challenges in the detection and interpretation of immunogenicity data. 4. Describe the potential prevention strategies in oncology. In oncology, an increasing number of targeted anticancer agents and immunotherapies are of biological origin. These biological drugs may trigger immune responses that lead to the fo...
Society For Translational Oncology

The Oncologist: The Width of the Surgical Margin Does Not Influence Outcomes in Extremity and Truncal Soft Tissue Sarcoma Treated With Radiotherapy

Learning Objectives: 1. Describe the necessity of achieving a negative margin in patients undergoing radiation therapy and limb-sparing surgery for soft tissue sarcomas in order to optimize local disease control and survival. 2. Explain the effect on outcome of wide margins of resection of soft tissue sarcomas treated with radiation therapy. 3. Discuss the application (if any) of the conclusions drawn from this study to patients undergoing surgery alone as the local treatment of their STS. ...
Society For Translational Oncology

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.